Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

Literature DB >> 9330458

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

T J Chambers¹, T F Tsai, Y Pervikov, T P Monath.

Abstract

Entities: Species

Mesh：

Substances：

Year: 1997 PMID： 9330458 DOI： 10.1016/s0264-410x(97)00195-3

Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Authors: T P Monath; I Levenbook; K Soike; Z X Zhang; M Ratterree; K Draper; A D Barrett; R Nichols; R Weltzin; J Arroyo; F Guirakhoo
Journal: J Virol Date: 2000-02 Impact factor: 5.103

2. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Authors: F Guirakhoo; J Arroyo; K V Pugachev; C Miller; Z X Zhang; R Weltzin; K Georgakopoulos; J Catalan; S Ocran; K Soike; M Ratterree; T P Monath
Journal: J Virol Date: 2001-08 Impact factor: 5.103

3. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis.

Authors: Vivek Swarup; Joydeep Ghosh; Soumya Ghosh; Amit Saxena; Anirban Basu
Journal: Antimicrob Agents Chemother Date: 2007-06-18 Impact factor: 5.191

4. Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine.

Authors: Asato Kojima; Atsushi Yasuda; Hideki Asanuma; Toyokazu Ishikawa; Akihisa Takamizawa; Kotaro Yasui; Takeshi Kurata
Journal: J Virol Date: 2003-08 Impact factor: 5.103

5. Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors: David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal: Vaccine Date: 2010-01-22 Impact factor: 3.641

6. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.

Authors: Muslum Yildiz; Sumana Ghosh; Jeffrey A Bell; Woody Sherman; Jeanne A Hardy
Journal: ACS Chem Biol Date: 2013-10-28 Impact factor: 5.100

Review 7. Dengue and dengue hemorrhagic fever.

Authors: D J Gubler
Journal: Clin Microbiol Rev Date: 1998-07 Impact factor: 26.132